{"entity":{"type":"insider","cik":"0001822241","url":"/insider/0001822241","json_url":"/insider/0001822241.json","name":"MILESON GLENNA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2022-06-24","last":"2022-12-30","span_basis":"filed_date"},"name_variants":[{"name":"MILESON GLENNA","source":"filing","n_filings":2,"first_seen":"2022-06-24","last_seen":"2022-12-30"}],"transactions":[{"id":6193391,"accession":"0001209191-22-063009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-063009","line_url":"/filing/0001209191-22-063009#line-2","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001822241","owner_name":"MILESON GLENNA","owner_display_name":"MILESON GLENNA","owner_url":"/insider/0001822241","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.845,"price_display":"2.84","price_state":"stated","total_value":142250.0,"total_display":"142,250.00","total_whole":"142,250","shares_owned_after":159930.0,"shares_owned_after_display":"159,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider"},{"id":6728778,"accession":"0001209191-22-039342","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-039342","line_url":"/filing/0001209191-22-039342#line-3","is_derivative":false,"issuer_cik":"0001620463","issuer_name":"Athira Pharma, Inc.","issuer_ticker":"ATHA","issuer_name_source":null,"issuer_url":"/issuer/0001620463","owner_cik":"0001822241","owner_name":"MILESON GLENNA","owner_display_name":"MILESON GLENNA","owner_url":"/insider/0001822241","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2614.0,"shares_display":"2,614","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":7031.66,"total_display":"7,031.66","total_whole":"7,032","shares_owned_after":109167.0,"shares_owned_after_display":"109,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001620463","name":"Athira Pharma, Inc.","url":"/issuer/0001620463","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2022-06-24","last_seen":"2022-12-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001822241","retrieved_at":"2026-08-28T01:04:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}